AI Article Synopsis

  • Arctic charr and European grayling are susceptible to achromogenic atypical Aeromonas salmonicida (AAS), which threatens their restocking in Finland due to a lack of preventive measures.
  • The study examined AAS isolates from both fish species and found that AAS infections displayed different disease progression and pathology between the two species, even with the same bacterial strain used in experiments.
  • Genetic analysis revealed that AAS isolates were identical within specific river basins but varied across different basins, indicating potential for developing a common vaccine to protect both fish species from AAS infection.

Article Abstract

Cultured stocks of Arctic charr Salvelinus alpinus and European grayling Thymallus thymallus are vulnerable to infection by achromogenic atypical Aeromonas salmonicida (AAS). In Finland, natural stocks of both fish species have to be supported by restocking, and AAS infection poses a threat to successful restocking because no preventive means are available. In this study, we analysed AAS isolates from Arctic charr and European grayling and from other sources genetically, and characterised the signs and pathology of AAS infection in Arctic charr and European grayling both under farming conditions and after experimental challenge. AAS outbreaks were recorded in 1 fish farm over an 8 yr period. Among various salmonid fishes under farming conditions, only Arctic charr and European grayling were susceptible to AAS infection. The disease caused by AAS could be reproduced in both species using the same AAS strain in an experimental challenge. The course of the disease and pathology of natural and experimental AAS infection differed between the 2 species, even though only 1 strain was used for challenge. Isolates of AAS from Arctic charr and European grayling were genetically identical within a single river water basin. However, genetic heterogeneity was observed among the isolates from different water basins. In both species, AAS caused systemic infection. The results suggest that the same AAS strain could be used to develop a vaccine to protect both Arctic charr and European grayling from AAS infection.

Download full-text PDF

Source
http://dx.doi.org/10.3354/dao066121DOI Listing

Publication Analysis

Top Keywords

arctic charr
28
european grayling
28
aas infection
20
charr european
20
aas
13
atypical aeromonas
8
aeromonas salmonicida
8
infection
8
infection arctic
8
charr salvelinus
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!